ESR1 and ductal breast carcinoma in situ: Regarding studies on the role of immune cells in the biology of breast DCIS [24], Hendry et al. reported that tumor infiltrating lymphocytes (TILs) were significantly greater in high-grade, ER-negative, and HER2-positive tumors of DCIS [25].